For healthcare professionals only


Detection of prostate cancer

BMJ 1995; 310 doi: (Published 29 April 1995) Cite this as: BMJ 1995;310:1139

Recent evidence suggests screening may be justified in high risk younger men

  1. William Foulkes
  1. Medical scientist Division of Medical Genetics, Department of Medicine, McGill University, Montreal General Hospital, Montreal, Quebec H39 1A4, Canada

    EDITOR,—Screening for prostate cancer has been the subject of much debate, and Fritz H Schroder considers the published data.1 His conclusion that population based screening is not yet justified is fair. There is much anxiety that screening for prostate specific antigen will detect a large number of indolent cancers, whose detection will not decrease mortality, and because of false positive results morbidity and mortality may be increased.1 2 Recent data from a nested case-control study, however, are an important addition to knowledge. …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription